- Review
- Open access
- Published:
Identifying key risk factors for the recurrence of benign paroxysmal positional vertigo following successful canalith repositioning maneuvers: a meta analysis
European Journal of Medical Research volume 30, Article number: 262 (2025)
Abstract
Background
An increasing occurrence trend of benign paroxysmal positional vertigo (BPPV) after successful canalith repositioning maneuvers was observed; however, the risk elements for the occurrence of this disease remain undefined. We aimed to conduct a meta-analysis of BPPV occurrence-associated risk factors reported.
Methods
A comprehensive search in MEDLINE, EMBASE, PubMed, Springer, and the Cochrane Library up to March 31, 2024. The meta-analysis was carried out with STATA 16.0. Quality evaluation of the articles was performed with the Newcastle–Ottawa Scales (NOS). Data were pooled by a random‐effects model. The meta-analysis was registered at INPLASY (202430045).
Results
Seventeen studies with 229 patients were included in the present analysis. The recurrence rate of BPPV after Canalith repositioning procedure (CRP) or Epley maneuver in subjects with hypertension [standardized mean difference (SMD) = 0.88,95% confidence interval (CI) (0.81–0.96), P = 0.00], Meniere’s disease [SMD = 0.84, 95%CI (0.57–1.10), P = 0.00], head trauma [SMD = 0.48, 95%CI (0.34–0.63), P = 0.00], diabetes mellitus (DM) [SMD = 0.87, 95%CI (0.80–0.94), P = 0.00], advanced age [SMD = 0.18, 95%CI (0.08–0.28), P = 0.00], osteoporosis [SMD = 0.32, 95%CI (0.20–0.43), P = 0.00], female gender [SMD = 0.53, 95%CI (0.40–0.67), P = 0.00], migraine headache [SMD = 0.20, 95%CI (0.06–0.35), P = 0.01], and vitamin D deficiency [OR = 0.29, 95%CI (0.18–0.40), P = 0.00] were appreciably higher than those in patients without hypertension, Meniere’s disease, head trauma, DM, advanced age, osteoporosis, female gender, migraine headache, and vitamin D deficiency.
Conclusion
This meta-analysis has identified several significant risk factors associated with the recurrence of BPPV following successful canalith repositioning procedures. These include Meniere’s disease, head trauma, diabetes mellitus, migraine headaches, female gender, advanced age, osteoporosis, and vitamin D deficiency.
Introduction
Benign paroxysmal positional vertigo (BPPV) is a common peripheral vertigo in the clinic, which is characterized by transient and recurrent intense vertigo caused by a head position change in gravity direction, accompanied by nystagmus [1]. BPPV usually occurs in middle-aged and older adults, accounting for 20 to 40% of peripheral vertigo, and its lifetime prevalence rate is about 2.4% [2]. The main characteristics of BPPV are recurrent, self-limited, transient, and high recurrence rate [3]. BPPV is generally divided into two categories according to etiology: secondary BPPV, has definite or possible causes, such as secondary Meniere’s disease, idiopathic sudden deafness, vestibular neuritis, otitis media, and head trauma, among others; primary BPPV (or idiopathic BPPV), the etiology of most diseases is not clear [4]. Patients with head position changes in daily life may experience vertigo, which has a severe impact on their lives and work [5].
Canalith repositioning procedure (CRP) is the most effective method for treating BPPV at present, and its effective rate is about 70%–90% [6]. Numerous studies have suggested the effectiveness of CRP in alleviating BPPV symptoms, with most patients reporting a decrease in dizziness following the therapeutic intervention [7]. However, various studies have confirmed that BPPV symptoms often recur after successful canalith repositioning maneuvers [8, 9]. Published studies showed that there are many factors affecting BPPV recurrence, such as age, sleep disorders, high blood pressure, diabetes, cervical spondylosis, bone mineral density, and among others [10]. How to reduce the recurrence of BPPV is a thorny problem troubling many clinicians. Despite numerous studies exploring the risk factors for BPPV recurrence [11, 12], inconsistencies in the results and a lack of a comprehensive overview have hindered the development of standardized clinical guidelines. There is a need for a synthesis of current evidence to identify consistent risk factors for BPPV recurrence. The present study performed a meta-analysis to investigate several recognized risk elements connected to BPPV after successful CRP or Epley maneuvers and to explore whether they have clinical significance.
Methods
Protocol
The current meta-analysis followed the preferred reporting items for systematic reviews and meta-analysis (PRISMA) protocol. The meta-analysis was registered at INPLASY (International Platform of Registered Systematic Review and Meta-analysis Protocols, 202430045).
Literature searching
We searched for articles on MEDLINE, EMBASE, PubMed, Springer, and the Cochrane Library up to March 31, 2024. A detailed search strategy was developed using a combination of Medical Subject Headings (MeSH) terms and free-text keywords to ensure the retrieval of all relevant studies. The search terms included: “benign paroxysmal positional vertigo,” “BPPV,” “BPV,” “recurrence,” “risk factor,” “canalith repositioning procedure,” “CRP,” “hypertension,” “osteoporosis,” “vitamin D deficiency” “diabetes,” “migraine,” “Meniere disease,” “sudden deafness,” and “head trauma.” Two independent reviewers carried out the search process and assessed all included articles. Disagreements were determined through discussion.
Selection criteria
The inclusion criteria were employed: (1) Case–control study or cohort study reporting the risk factors for BPPV recurrence; (2) studies that reported OR accompanied by 95% CI to quantify the strength of the association between risk factors and BPPV recurrence; (3) studies with complete data, including the number of recurrent and non-recurrent cases; (4) follow-up period ≥ 6 months. Reviews, case reports, conference abstracts, duplicated studies, and/or studies with insufficient data were excluded from this study.
Data extraction
The following data were extracted by two reviewers (Wen YL, Fan YY): first author, publication year, country, study design, follow-up time, population, sample size (trial/control), outcome indicators, and results. Any inconsistencies were determined by discussion with the third author (Jian BS).
Quality evaluation and publication bias
The NOS was used for the quality evaluation. Two independent authors carried out the quality evaluation. Publication bias was measured by Deeks’ funnel plot asymmetry test.
Statistical analysis
The statistical analysis was conducted using STATA 16.0 software. All statistical assumptions, including the normality of the data and the homogeneity of variances, were tested prior to conducting the meta-analysis. These tests helped to validate the appropriateness of the statistical methods used. To handle missing data, we adopted a conservative approach by imputing values where necessary, using the best available data from similar studies or applying established statistical techniques to ensure the integrity of our analysis. The choice of imputation method was based on the nature of the data and the extent of the missing information. A random-effects model was selected for data pooling in the analysis. This model accounts for both between-study and within-study variability, which is particularly relevant when comparing the recurrence rates of BPPV after CRP in diverse patient groups. The random-effects model provides a more conservative estimate of the effect size, reflecting the inherent variability across studies. By employing this model, we were able to account for the differences in clinical settings, treatment protocols, and patient demographics that contribute to the observed heterogeneity in the data. To further assess heterogeneity within the context of the random-effects model, we calculated the I2 statistic and the tau-squared (τ2) value. The I2 statistic measures the proportion of total variation across studies that is attributable to heterogeneity rather than chance. The τ2 value represents the estimated true heterogeneity among studies, which is the underlying between-study variance. These measures, along with the Q-test, were used to evaluate the degree of between-study variance. Sensitivity analyses were conducted using a leave-one-out approach to assess the robustness of the pooled estimates. A funnel plot was employed to investigate publication bias, and Deeks’ funnel plot asymmetry test was conducted to quantify the potential bias. The combined effects were estimated, and P < 0.05 was considered statistically significant.
Results
Article selection
Our retrieval strategy obtained 432 articles. Of the 432 potentially appropriate studies, 160 articles were initially disqualified for duplication. After assessing titles and abstracts, 59 articles were disqualified for irrelevance to our purpose. Next, 84 studies were disqualified for the following reasons: no full manuscript accessible, being an inappropriate study design, having a study population aged less than 18 years, and insufficient data. Finally, the full-text assessment generated 17 articles that satisfied the selection criteria; 17 studies were involved in the current meta-analysis. The overview of the article selection is exhibited in Fig. 1, and the features of the 17 involved articles are summed up in Table 1. Our meta-analysis has synthesized evidence from studies that, based on the Newcastle–Ottawa Scales, demonstrate a moderate to high level of quality (Table 1).
BPPV accompanied by hypertension
Three studies have evaluated whether the recurrence of BPPV after successful CRP was associated with hypertension. As indicated in Fig. 2, the recurrence rate of BPPV in patients with hypertension was markedly higher than that in patients without hypertension [SMD = 0.88, 95%CI (0.81–0.96), P = 0.00].
BPPV accompanied by DM
Four studies have evaluated whether recurrence of BPPV after reduction was associated with DM. The results showed that the recurrence rate of BPPV in patients with DM was markedly higher than that in patients without DM [SMD = 0.87, 95%CI (0.80–0.94), P = 0.00, Fig. 3].
BPPV accompanied by migraine headache
Four studies have evaluated whether the recurrence of BPPV after reduction was associated with migraine headaches. The results showed that the recurrence rate of BPPV in patients with migraine headaches was markedly higher than that in patients without migraine headaches [SMD = 0.20, 95%CI (0.06–0.35), P = 0.01, Fig. 4].
BPPV accompanied by Meniere’s disease
Four studies have evaluated whether recurrence of BPPV after reduction was associated with Meniere’s disease. As exposed in Fig. 5, the recurrence ratio of BPPV in patients with Meniere’s disease was considerably higher than that in patients without Meniere’s disease [SMD = 0.84, 95%CI (0.57–1.10), P = 0.00].
BPPV accompanied by head trauma
Nine studies have assessed whether the recurrence of BPPV after CRP was associated with head trauma. As shown in Fig. 6, the recurrence rate of BPPV after CRP or Epley maneuver in patients with head trauma was considerably higher than that in patients without head trauma [SMD = 0.48, 95%CI (0.34–0.63), P = 0.00].
Influence of advanced age on BPPV recurrence
Three studies have evaluated whether the recurrence of BPPV after CRP was associated with advanced age (Fig. 7). The results showed that the recurrence rate of BPPV after CRP or Epley maneuver in patients with advanced age was markedly increased compared with that in younger patients [SMD = 0.18, 95%CI (0.08–0.28), P = 0.00].
Influence of female gender on BPPV recurrence
Five studies have evaluated whether the recurrence of BPPV after CRP was associated with female gender (Fig. 8). The results showed that the recurrence rate of BPPV after CRP or Epley maneuver in female patients was markedly increased compared with that in male patients [SMD = 0.53, 95%CI (0.40–0.67), P = 0.00].
BPPV accompanied by osteoporosis
Four studies have evaluated whether recurrence of BPPV after reduction was associated with osteoporosis (Fig. 9). The results showed that the recurrence rate of BPPV after CRP or Epley maneuver in patients with osteoporosis was markedly increased compared with that in patients without osteoporosis [SMD = 0.32, 95%CI (0.20–0.43), P = 0.00].
BPPV accompanied by vitamin D deficiency
Three studies have evaluated whether recurrence of BPPV after reduction was associated with vitamin D deficiency (Fig. 10). The results showed that the recurrence rate of BPPV after CRP or Epley maneuver in patients with vitamin D deficiency was markedly increased compared with that in patients without vitamin D deficiency [OR = 0.29, 95%CI (0.18–0.40), P = 0.00].
Publication bias
The funnel plots associated with the outcomes displayed significant symmetry (Fig. 11). The significant symmetry in the funnel plots suggests that the dataset is likely free from significant publication bias, which enhances the validity and reliability of the findings.
Analysis of publication bias. A publication bias for hypertension; B publication bias for DM; C publication bias for migraine headache; D publication bias for Meniere’s disease; E publication bias for head trauma; F publication bias for advanced age; G publication bias for female gender; H publication bias for osteoporosis; I publication bias for vitamin D deficiency. DM Diabetes Mellitus
Discussion
The current meta-analysis investigated the risk factors associated with the recurrence of BPPV following successful canalith repositioning procedures. Research has suggested that chronic hypertension may lead to widespread vascular damage and atherosclerosis, which can result in injury to the inner ear’s blood vessels and the gradual separation of otoliths from the otolithic membrane [13]. Przewoźny and colleagues [14] have proposed that ischemia, a condition associated with hypertension, may contribute to the formation of more otolith residue, necessitating additional treatments to alleviate vertigo. Casani et al. have demonstrated that hypertension is a factor that may increase the likelihood of BPPV recurrence [15]. Our meta-analysis further identified a significant link between the coexistence of hypertension and DM and a higher recurrence rate of BPPV. It is well-established in the literature that DM can lead to neurodegenerative conditions and inner ear ischemia, which may cause otolith shedding and increase the susceptibility to recurrent BPPV episodes [16]. Additional studies have highlighted that patients with both hypertension and DM face a significantly higher risk of BPPV recurrence [17].
Earlier work indicated that the ear symptoms of migraine patients may result from vasospasm or ion channel disorder [18]. Ishiyama et al. have also suggested that patients with migraines may play a role in inner ear injury due to repeated vasospasm or vestibular-microvascular disorder, resulting in otolith falling off and entering the semicircular canal, which quickly causes BPPV and persistent BPPV [19]. However, the study of Strupp et al. indicated that there was no marked difference between migraine and BPPV [20]. The direct pathophysiological relationship between BPPV and migraine has not been established. The results of this study showed that the recurrence rate of BPPV in patients with migraine headaches was markedly higher than that in patients without migraine headaches, suggesting that migraine was a critical risk element for BPPV recurrence. Meniere’s disease is a common vestibular disease, which is mainly characterized by paroxysmal vertigo, accompanied by fluctuating hearing loss, tinnitus, ear distension, and tightness. Emerging evidence indicates that BPPV, accompanied by Meniere’s disease, has an advanced recurrence rate, and requires multiple otolith repositioning. Consistent with this observation, this study has observed that the recurrence rate of BPPV in patients with Meniere’s disease was ominously enhanced compared to that in patients without Meniere’s disease, suggesting that Meniere’s disease is a risk element for recurrence of BPPV.
Head trauma is a common cause of secondary BPPV. Different natures and degrees of trauma may cause BPPV, such as traffic accidents and blunt head injuries [21]. Remarkably, it has been indicated that head trauma is a common cause of secondary BPPV [22]. Honoré et al. have suggested that head trauma may destroy the otolith membrane, forming post-traumatic BPPV [23]. Jensen et al. observe a high recurrence rate of post-traumatic BPPV, suggesting that the high recurrence of post-traumatic BPPV may be connected to head trauma [24]. This meta-analysis indicated that the recurrence rate of BPPV in patients with head trauma markedly increased, suggesting that head trauma was a risk element for the recurrence of BPPV.
Our meta-analysis also explored the influence of demographic factors on the recurrence of BPPV following canalith repositioning procedures. Regarding the impact of advanced age on BPPV recurrence, our findings revealed a significant association, with a higher recurrence rate observed in older patients. This is consistent with the notion that the aging process may accelerate the degeneration of the vestibular system and reduce cellular regeneration, thus predisposing older individuals to otolith detachment and BPPV recurrence [25]. Furthermore, our meta-analysis confirmed that female gender is a substantial risk factor for BPPV recurrence, with a marked increase in recurrence rates among female patients compared to males. This finding aligns with previous observations of gender disparities in BPPV recurrence, which may be attributed to hormonal or anatomical differences that affect otolith stability and ear function [26]. In addition to demographic factors, our analysis identified that patients with osteoporosis are at a higher risk of BPPV recurrence after canalith repositioning procedures. Osteoporosis, which affects bone density and integrity, may alter the structure of the otolith membrane, leading to increased otolith detachment and recurrence of BPPV symptoms [27]. The meta-analysis also highlighted the role of vitamin D deficiency in BPPV recurrence. Patients with vitamin D deficiency exhibited a significantly higher recurrence rate of BPPV after treatment. Given that vitamin D is crucial for bone health, its deficiency may contribute to the compromised integrity of the inner ear structures and the subsequent shedding of otoliths [28]. These findings underscore the importance of considering age, gender, and comorbid conditions such as osteoporosis and vitamin D deficiency when assessing the risk of BPPV recurrence.
In this meta-analysis, our findings contribute to the ongoing discourse on the risk factors for BPPV recurrence, particularly within the subset of patients who have undergone successful CRP. The discrepancy observed in the risk factors identified between our study and the studies by Sfakianaki et al. [29], Chen et al. [30], and Li et al. [31] can be attributed to several factors, most notably the difference in study populations. Our study focuses on patients who have experienced a recurrence of BPPV after a successful CRP, which is a specific population with a distinct clinical history and potential risk factors. The inclusion of patients only after a successful CRP allows for a more targeted analysis of the risk factors that contribute to BPPV recurrence in this post-treatment setting. In contrast, the studies by Sfakianaki et al., Chen et al., and Li et al. included a broader population of BPPV patients, some of whom have experienced recurrent episodes before undergoing any treatment, including CRP. This difference in the study population may explain the variations in the identified risk factors. Additionally, the temporal aspect of the risk factor assessment may play a role in the observed differences. Our study evaluates risk factors after a successful CRP, which may influence the risk profile differently than assessments conducted prior to any treatment. Factors such as the duration of follow-up, the definition of recurrence, and the criteria for successful CRP may also contribute to the heterogeneity of the findings across studies.
Our meta-analysis is subject to several key limitations. Firstly, the small sample sizes observed in certain studies included in our analysis may affect the precision of our estimated effect sizes and constrain the generalizability of our results. To mitigate this, we have utilized STATA 16 to conduct a more robust analysis. This approach allows for a more detailed of between-study variance and enhances the reliability of our findings. However, larger-scale research is still needed for validation purposes. Secondly, the paucity of studies incorporated into our analysis may not fully capture the underlying heterogeneity, potentially influencing the accuracy of our assessment. This limited number of studies also diminishes our statistical power, increasing the likelihood of overlooking smaller effect sizes or significant differences. To address these limitations, future research should aim to include a broader array of studies to bolster the reliability of the findings and enhance the statistical robustness of the analysis. Additionally, the retrospective nature of most of the studies introduces inherent biases in data collection and presents challenges in controlling for all potential confounders, which may affect the reliability of the evidence presented. Furthermore, we have identified selection bias, information bias, and confounding as additional sources of potential bias. Despite employing the Newcastle–Ottawa Scale for quality assessment, its scope may not encompass all facets of study quality, thus serving as an additional limitation. Lastly, the observed heterogeneity among studies, likely due to variations in design, populations, and measured outcomes, could influence the meta-analysis results, emphasizing the need for careful interpretation and further investigation. This heterogeneity is partially accounted for by the random-effects model we have used, which allows for the inclusion of between-study variability, but it also underscores the importance of conducting more extensive research to understand the factors contributing to this heterogeneity.
Conclusions
In conclusion, this meta-analysis has identified several factors that may be associated with an increased risk of BPPV recurrence post-canalith repositioning procedures. These include hypertension, diabetes mellitus, advanced age, female gender, vitamin D deficiency, a history of Meniere’s disease, osteoporosis, prior head trauma, and, importantly, migraine headaches. The findings underscore the complex interplay of demographic and clinical factors influencing BPPV recurrence. While these factors are indicative of potential recurrence risks, the evidence suggests that the associations may be complex and influenced by a range of variables. Therefore, while our findings point towards possible targets for intervention in high-risk patient populations, they also highlight the need for further research to establish causality and to develop evidence-based strategies that could reduce the incidence of BPPV recurrence and improve patient outcomes.
Availability data and materials
The data that support the findings of this study are available in JIANGUOYUN at https://www.jianguoyun.com/p/DY8-5W8QoM6KCxif3dUFIAA.
References
Kim HJ, Park J, Kim JS. Update on benign paroxysmal positional vertigo. J Neurol. 2021;268(5):1995–2000.
Koç A. Benign paroxysmal positional vertigo: is it really an otolith disease? J Int Adv Otol. 2022;18(1):62–70.
Nuti D, Zee DS, Mandalà M. Benign paroxysmal positional vertigo: what we do and do not know. Semin Neurol. 2020;40(1):49–58.
Kim HJ, Kim JS, Choi KD, Choi SY, Lee SH, Jung I, Park JH. Effect of self-treatment of recurrent benign paroxysmal positional vertigo: a randomized clinical trial. JAMA Neurol. 2023;80(3):244–50.
Lou Y, Cai M, Xu L, Wang Y, Zhuang L, Liu X. Efficacy of BPPV diagnosis and treatment system for benign paroxysmal positional vertigo. Am J Otolaryngol. 2020;41(3): 102412.
Imai T, Inohara H. Benign paroxysmal positional vertigo. Auris Nasus Larynx. 2022;49(5):737–47.
Zuniga SA, Marmor S, Adams ME. Variation in canalith repositioning procedure use among medicare beneficiaries: understanding the role of geographic region and provider specialty. Otol Neurotol. 2021;42(7):e911–7.
Balatsouras DG, Koukoutsis G, Fassolis A, Moukos A, Apris A. Benign paroxysmal positional vertigo in the elderly: current insights. Clin Interv Aging. 2018;13:2251–66.
Tirelli G, Nicastro L, Gatto A, Tofanelli M. Repeated canalith repositioning procedure in BPPV: effects on recurrence and dizziness prevention. Am J Otolaryngol. 2017;38(1):38–43.
Ismail EI, Morgan AE, Abdeltawwab MM. Home particle repositioning maneuver to prevent the recurrence of posterior canal BPPV. Auris Nasus Larynx. 2018;45(5):980–4.
Çetin YS, Çağaç A, Düzenli U, Bozan N, Elasan S. Residual dizziness in elderly patients after benign paroxysmal positional vertigo. ORL J Otorhinolaryngol Relat Spec. 2022;84(2):122–9.
Su P, Liu YC, Lin HC. Risk factors for the recurrence of post-semicircular canal benign paroxysmal positional vertigo after canalith repositioning. J Neurol. 2016;263(1):45–51.
Jordan J, Ricci F, Hoffmann F, Hamrefors V, Fedorowski A. Orthostatic hypertension: critical appraisal of an overlooked condition. Hypertension. 2020;75(5):1151–8.
Przewoźny T, Gójska-Grymajło A, Kwarciany M, Gąsecki D, Narkiewicz K. Hypertension and cochlear hearing loss. Blood Press. 2015;24(4):199–205.
Casani AP, Gufoni M. Recurring benign paroxysmal positional vertigo after successful canalith repositioning manoeuvers. Acta Otorhinolaryngol Ital. 2023;43(Suppl 1):S61-s66.
Deng Y, Chen S, Hu J. Diabetes mellitus and hearing loss. Mol Med. 2023;29(1):141.
Song N, Wu Y, Li X, Wang Q, Ma X, Yang X. Geriatric benign paroxysmal positional vertigo: a single-center study. Braz J Otorhinolaryngol. 2023;89(4): 101277.
Abouzari M, Tawk K, Lee D, Djalilian HR. Migrainous vertigo, tinnitus, and ear symptoms and alternatives. Otolaryngol Clin North Am. 2022;55(5):1017–33.
Benjamin T, Gillard D, Abouzari M, Djalilian HR, Sharon JD. Vestibular and auditory manifestations of migraine. Curr Opin Neurol. 2022;35(1):84–9.
Strupp M, Dlugaiczyk J, Ertl-Wagner BB, Rujescu D, Westhofen M, Dieterich M. Vestibular disorders. Dtsch Arztebl Int. 2020;117(17):300–10.
Hung KL. Pediatric abusive head trauma. Biomed J. 2020;43(3):240–50.
Yetiser S. Review of the pathology underlying benign paroxysmal positional vertigo. J Int Med Res. 2020;48(4):300060519892370.
Honoré TV, West N, Klokker M. Benign paroxysmal positional vertigo is an overlooked complication of head trauma. Ugeskr Laeger. 2019;181(10):V09180605.
Jensen JK, Hougaard DD. Incidence of benign paroxysmal positional vertigo and course of treatment following mild head trauma-is it worth looking for? J Int Adv Otol. 2022;18(6):513–21.
Maas B, Hacarlioglugil E, van Leeuwen RB, Kamphuis S, Schermer TR, van Benthem PPG, Bruintjes TD. Risk factors for recurrence of benign paroxysmal positional vertigo: a prospective study. Otol Neurotol. 2024;45(8):932–8.
Evans A, Frost K, Wood E, Herdman D. Management of recurrent benign paroxysmal positional vertigo. J Laryngol Otol. 2024;138(S2):S18-s21.
Bashir K, Yousuf A, Shahzad T, Khan K, Khuda Bakhsh Z. Benign paroxysmal positional vertigo after joint replacement surgeries: case series. Cureus. 2024;16(1): e51839.
Rhim G, Kim MJ. Vitamin D supplementation and recurrence of benign paroxysmal positional vertigo. Nutrients. 2024;16(5):689.
Sfakianaki I, Binos P, Karkos P, Dimas GG, Psillas G. Risk factors for recurrence of benign paroxysmal positional vertigo. A clinical review. J Clin Med. 2021;10(19):4372.
Chen J, Zhang S, Cui K, Liu C. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis. J Neurol. 2021;268(11):4117–27.
Li S, Wang Z, Liu Y, Cao J, Zheng H, Jing Y, Han L, Ma X, Xia R, Yu L. Risk factors for the recurrence of benign paroxysmal positional vertigo: a systematic review and meta-analysis. Ear Nose Throat J. 2022;101(3):np112–34.
Choi SJ, Lee JB, Lim HJ, Park HY, Park K, In SM, Oh JH, Choung YH. Clinical features of recurrent or persistent benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2012;147(5):919–24.
Webster G, Sens PM, Salmito MC, Cavalcante JDR, Souza RCFD. Hyperinsulinemia and hypoglycemia: risk factors for recurrence of benign paroxysmal positional vertigo. Braz J Otorhinolaryngol. 2015;33(4):347–51.
Balatsouras DG, Ganelis P, Aspris A, Economou NC, Moukos A, Koukoutsis G. Benign paroxysmal positional vertigo associated with Meniere’s disease: epidemiological, pathophysiologic, clinical, and therapeutic aspects. Ann Otol Rhinol Laryngol. 2012;121(10):682–8.
Babac S, Djeric D, Petrovic-Lazic M, Arsovic N, Mikic A. Why do treatment failure and recurrences of benign paroxysmal positional vertigo occur? Otol Neurotol. 2014;35(6):1105–10.
Luryi AL, Lawrence J, Bojrab DI, LaRouere M, Babu S, Zappia J, Sargent EW, Chan E, Naumann I, Hong RS, et al. Recurrence in benign paroxysmal positional vertigo: a large. Single-Institution Study Otol Neurotol. 2018;39(5):622–7.
Dornhoffer JL, Colvin GB. Benign paroxysmal positional vertigo and canalith repositioning: clinical correlations. Am J Otol. 2000;21(2):230–3.
Ogun OA, Janky KL, Cohn ES, Büki B, Lundberg YW. Gender-based comorbidity in benign paroxysmal positional vertigo. PLoS ONE. 2014;9(9): e105546.
Kansu L, Avci S, Yilmaz I, Ozluoglu LN. Long-term follow-up of patients with posterior canal benign paroxysmal positional vertigo. Acta Otolaryngol. 2010;130(9):1009–12.
De Stefano A, Dispenza F, Suarez H, Perez-Fernandez N, Manrique-Huarte R, Ban JH, Kim MB, Strupp M, Feil K, Oliveira CA, et al. A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx. 2014;41(1):31–6.
Tan J, Deng Y, Zhang T, Wang M. Clinical characteristics and treatment outcomes for benign paroxysmal positional vertigo comorbid with hypertension. Acta Otolaryngol. 2017;137(5):482–4.
Del Rio M, Arriaga MA. Benign positional vertigo: prognostic factors. Otolaryngol Head Neck Surg. 2004;130(4):426–9.
Ahn SK, Jeon SY, Kim JP, Park JJ, Hur DG, Kim DW, Woo SH, Kwon OJ, Kim JY. Clinical characteristics and treatment of benign paroxysmal positional vertigo after traumatic brain injury. J Trauma. 2011;70(2):442–6.
Picciotti PM, Lucidi D, De Corso E, Meucci D, Sergi B, Paludetti G. Comorbidities and recurrence of benign paroxysmal positional vertigo: personal experience. Int J Audiol. 2016;55(5):279–84.
Song CI, Kang BC, Yoo MH, Chung JW, Yoon TH, Park HJ. Management of 210 patients with benign paroxysmal positional vertigo: AMC protocol and outcomes. Acta Otolaryngol. 2015;135(5):422–8.
Balatsouras DG, Koukoutsis G, Aspris A, Fassolis A, Moukos A, Economou NC, Katotomichelakis M. Benign paroxysmal positional vertigo secondary to mild head trauma. Ann Otol Rhinol Laryngol. 2017;126(1):54–60.
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
Yanling Wen: Conceptualization, Investigation, Methodology. Yiyan Fan: Conceptualization, Data Curation, Supervision. Baoshan Jian: Data Curation, Methodology, Writing—Original Draft.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wen, Y., Fan, Y. & Jian, B. Identifying key risk factors for the recurrence of benign paroxysmal positional vertigo following successful canalith repositioning maneuvers: a meta analysis. Eur J Med Res 30, 262 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40001-025-02482-x
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40001-025-02482-x